DR. Josephine Amalia Taverna, M.D. is a medical oncology internal medicine in Akron, OH with 20 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. DR. Josephine Amalia Taverna, M.D. NPI is 1629283833. The provider is registered as an individual entity type.
The NPPES NPI record indicates the provider is a female.
The provider's business location address is:
400 WABASH AVE
AKRON, OH
ZIP 44307-433
Phone: (330) 344-6000
The NPI 1629283833 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.
The CLIA number assigned to this NPI record is 45D1041166 - physician office with a certificate type of Certificate of Waiver.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Injection, fosaprepitant, 1 mg (HCPCS:J1453)
- Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
- Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
- Injection of different drug or substance into a vein for therapy, diagnosis, or prevention (HCPCS:96375)
- Infusion of chemotherapy into a vein up to 1 hour (HCPCS:96413)
- Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour (HCPCS:96367)
- Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour (HCPCS:96365)
- Injection beneath the skin or into muscle for therapy, diagnosis, or prevention (HCPCS:96372)
The enumeration date for this NPI number is 5/11/2007 and was last updated on 3/17/2018.